Zafirlukast for Asthma: Uses, Dosage & Side Effects

What is Zafirlukast?

Zafirlukast is an oral medication belonging to a class of drugs called leukotriene receptor antagonists (LTRAs). The medication is commonly known by its brand name Accolate and is used for the prevention and long-term treatment of asthma symptoms in adults and children aged 5 years and older. Unlike rescue inhalers that provide immediate relief during an acute asthma attack, zafirlukast is designed for regular, daily use to control ongoing asthma symptoms and prevent attacks from occurring.

Zafirlukast represents an important treatment option for individuals with persistent asthma who require daily medication to manage their condition effectively. The medication works systemically throughout the body to reduce inflammatory responses in the airways, making breathing easier and reducing the frequency and severity of asthma symptoms over time.

How Does Zafirlukast Work?

Zafirlukast operates through a specific mechanism that targets the inflammatory process underlying asthma. The medication functions as an antagonist of cysteinyl leukotriene receptor 1 (CysLT1), a receptor found throughout the smooth muscle of the lungs and within interstitial lung macrophages (specialized white blood cells in the lungs). By blocking this receptor, zafirlukast prevents leukotrienes—natural substances in the body that cause inflammation and swelling—from triggering airway constriction.

The inflammatory pathway that zafirlukast interrupts involves leukotrienes binding to CysLT1 receptors, which normally causes the airways to narrow and become inflamed. This is a key mechanism in asthma pathophysiology. When zafirlukast blocks these receptors, it reduces the production of inflammatory mediators implicated in asthma development. This results in decreased inflammation of the airways, improved airflow, and easier breathing for patients with chronic asthma.

Importantly, zafirlukast is extensively metabolized in the liver by an enzyme called CYP2C9, which is relevant for understanding potential drug interactions. The medication’s action on inflammatory cells means it addresses the root cause of asthma symptoms rather than simply masking them temporarily.

Uses and Medical Applications

Zafirlukast has been FDA-approved for multiple asthma-related conditions beyond general asthma management. The primary uses include:

• Mild to Moderate Asthma Prevention: Zafirlukast is used to prevent asthma attacks and manage symptoms in patients with chronic asthma of varying severity levels.
• Seasonal Allergic Asthma: The medication helps control asthma symptoms triggered by seasonal allergens such as pollen.
• Exercise-Induced Asthma: Zafirlukast can be taken to prevent breathing difficulties that occur during or after physical exercise.
• Aspirin-Induced Asthma: For individuals who experience asthma symptoms triggered by aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), zafirlukast offers preventive benefits.
• Allergic Rhinitis: The medication is sometimes prescribed off-label to manage hay fever symptoms, including runny nose and watery eyes caused by allergic reactions.

However, it is crucial to understand that zafirlukast is not effective for treating acute asthma attacks. The medication requires regular daily use to be effective and does not provide the rapid relief needed during sudden airway obstruction. Patients must maintain a separate rescue inhaler containing a short-acting beta-2 agonist for emergency asthma attacks.

Dosage and Administration

The proper dosage of zafirlukast depends on the patient’s age and must be determined by a healthcare provider. The standard dosing regimens are:

Zafirlukast is available as an oral tablet and should be taken exactly as prescribed by your doctor. The medication is best taken on an empty stomach, one hour before or two hours after meals, as food can reduce its absorption. Patients should continue taking zafirlukast regularly, even when feeling well, as the medication works to prevent symptoms rather than treat them once they occur.

Do not stop taking zafirlukast or change your dosage without consulting your healthcare provider, even if your asthma symptoms improve. Abruptly discontinuing the medication may lead to a return of symptoms or potential asthma exacerbations.

Common Side Effects

While zafirlukast is generally well tolerated, certain side effects are relatively common and typically mild. The most frequently reported adverse effects include:

• Headache: The most commonly reported side effect, occurring in a significant proportion of patients.
• Nausea and Stomach Upset: Gastrointestinal discomfort, including nausea, vomiting, and abdominal pain, is common.
• Diarrhea: Some patients experience loose or watery stools.
• Dizziness: A sense of lightheadedness or vertigo may occur.
• Muscle Aches: Some patients report generalized myalgia or joint pain.

These side effects are typically mild to moderate and often diminish as the body adjusts to the medication. Most patients find these effects manageable and do not require discontinuation of therapy. However, if side effects are persistent or bothersome, inform your healthcare provider, who may adjust your dosage or recommend alternative treatments.

Serious Side Effects Requiring Immediate Medical Attention

Although rare, zafirlukast can cause serious adverse effects that require prompt medical evaluation. Patients should seek immediate medical attention if they experience:

• Liver Problems: Signs include yellowing of the skin or eyes (jaundice), severe nausea, dark urine, abdominal pain on the upper right side, and unusual fatigue. These symptoms may indicate liver dysfunction or failure, a potentially life-threatening condition.
• Severe Allergic Reactions: Symptoms include rash, hives, swelling of the face or throat, and difficulty breathing.
• Eosinophilic Granulomatosis with Polyangiitis (EGPA): This rare but serious condition involves inflammation of blood vessels and can cause symptoms similar to asthma exacerbation. While EGPA has been associated with zafirlukast use, the relationship is not thought to be causative, and cases may represent previously undiagnosed EGPA.
• Severe Muscle or Joint Pain: Unexplained severe pain may indicate a more serious condition.

If you experience any of these symptoms, contact your healthcare provider immediately or seek emergency medical care.

Drug Interactions and Precautions

Zafirlukast may interact with certain medications, potentially altering their effectiveness or causing adverse effects. A notable interaction occurs with theophylline, a medication sometimes used in asthma management. When zafirlukast is taken with theophylline, plasma concentrations of zafirlukast may decrease by approximately 30%.

Before starting zafirlukast, inform your healthcare provider of all medications you are currently taking, including over-the-counter drugs, supplements, and herbal products. Your doctor will assess potential interactions and adjust your treatment plan accordingly.

Patients with liver disease should use zafirlukast with caution, as the medication undergoes hepatic metabolism. Periodic monitoring of liver function through blood tests may be necessary during zafirlukast treatment.

Overdose Information

In cases of zafirlukast overdose, the medication tends to be self-limiting, meaning the body naturally eliminates excess drug over time. The highest overdose reported involved 200 mg, and all patients who overdosed survived. Symptoms of overdose are typically mild and may include rash and stomach upset. If overdose is suspected, contact a poison control center or emergency medical services immediately.

Comparison with Other Asthma Medications

While zafirlukast is useful for long-term asthma management, it is generally less effective than inhaled glucocorticoids (corticosteroids) used as monotherapy or long-acting beta-2 agonists used in combination therapy. Inhaled corticosteroids remain the standard of care for persistent asthma and are typically more potent anti-inflammatory agents. However, zafirlukast may be an appropriate alternative for patients who cannot tolerate inhaled medications or require additional control beyond standard therapy.

Important Reminders About Use

Zafirlukast may help control asthma symptoms, but it does not cure asthma. The condition remains present, but symptoms are managed through regular medication use. Key points to remember include:

• Continue all other asthma medications prescribed by your doctor unless specifically told otherwise.
• Do not use zafirlukast to treat sudden asthma attacks; use a rescue inhaler instead.
• Always have your rescue inhaler with you at all times.
• Take zafirlukast regularly as prescribed, even when feeling well.
• Do not stop taking zafirlukast without consulting your healthcare provider.
• Inform all healthcare providers that you are taking zafirlukast.

Frequently Asked Questions About Zafirlukast

Q: Can zafirlukast be used to treat an acute asthma attack?

A: No. Zafirlukast is designed for long-term prevention and symptom control, not emergency treatment. You must have a quick-relief inhaler available for acute asthma attacks.

Q: How long does it take for zafirlukast to work?

A: Zafirlukast requires regular daily use to be effective. Some patients notice improvement within days, while others may take weeks to experience full benefits. Consistent use is essential for optimal results.

Q: Is zafirlukast safe for children?

A: Yes, zafirlukast is FDA-approved for children 5 years and older. Children younger than 5 years require individualized dosing determined by a healthcare provider.

Q: What should I do if I miss a dose?

A: Take the missed dose as soon as you remember, unless it is nearly time for your next scheduled dose. Do not double-dose to make up for a missed dose.

Q: Can I drink alcohol while taking zafirlukast?

A: While moderate alcohol consumption is generally considered safe, heavy alcohol use may stress the liver. Discuss alcohol consumption with your healthcare provider.

Q: Does zafirlukast cause weight gain?

A: Weight gain is not a commonly reported side effect of zafirlukast. If you experience unexplained weight changes, discuss this with your healthcare provider.

Q: Can I take zafirlukast while pregnant?

A: Consult your healthcare provider about zafirlukast use during pregnancy. Your doctor will assess the risks and benefits based on your individual health situation.

When to Contact Your Healthcare Provider

Contact your doctor if you experience persistent headaches, severe nausea, yellowing of the skin or eyes, dark urine, abdominal pain, unusual fatigue, or signs of allergic reaction. Additionally, inform your provider if your asthma symptoms are not improving after several weeks of consistent zafirlukast use, or if you experience increased frequency of asthma attacks despite regular medication use.

Conclusion

Zafirlukast (Accolate) is an important medication for the long-term prevention and management of chronic asthma in both children and adults. By blocking leukotriene receptors and reducing airway inflammation, zafirlukast helps patients maintain better control over their asthma symptoms and improves overall quality of life. While side effects are generally mild and manageable, patients should remain alert to rare but serious adverse effects and maintain regular communication with their healthcare providers. Remember that zafirlukast is a preventive medication that must be taken consistently and cannot replace rescue medications for acute asthma attacks.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb